The American Heart Association and the American College of Cardiology joint guideline addressing cardiovascular evaluation ...
SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.
Recurrent stroke risk was lower among patients with type 2 diabetes who used SGLT2 inhibitors within 3 months of ischemic stroke.
Canada: Recent post hoc analyses from the VERTIS CV trial reveal promising results for ertugliflozin, a medication used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback